Back
Xeris Biopharma Holdings Vs. Griffon Industry Stock Comparison
Buy
77
XERS
Xeris Biopharma Holdings
Last Price:
3.06
Seasonality Move:
-0.27%
Buy
70
GFF
Griffon
Last Price:
77.38
Seasonality Move:
14.29%
Buy
77
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $3.15. The Score for XERS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Griffon (GFF)
is a Buy
Is Griffon a Buy, Sell or Hold?
- The current Griffon [GFF] share price is $80.52. The Score for GFF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- GFF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $3.15
The current trend is moderately bearish and XERS is experiencing selling pressure, which indicates risk of future bearish movement.
XERS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 50.18 | Buy |
| Chaikin Money Flow: | -1864095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3 - 3.3) | Sell |
| Bollinger Bands (100): | (2.37 - 3.07) | Buy |
GFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.42 | Buy |
| Relative Strength Index (14 RSI): | 78.19 | Buy |
| Chaikin Money Flow: | 1692432 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.12 - 70.34) | Buy |
| Bollinger Bands (100): | (62.68 - 70.2) | Buy |
XERS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.28 | Sell |
| 20-day SMA: | 3.2 | Sell |
| 50-day SMA: | 2.99 | Buy |
| 200-day SMA: | 2.49 | Buy |
| 8-day EMA: | 3.24 | Sell |
| 20-day EMA: | 3.19 | Sell |
| 50-day EMA: | 3.01 | Buy |
| 200-day EMA: | 2.57 | Buy |
GFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.94 | Buy |
| 20-day SMA: | 66.4 | Buy |
| 50-day SMA: | 66.92 | Buy |
| 200-day SMA: | 67.26 | Buy |
| 8-day EMA: | 70.29 | Buy |
| 20-day EMA: | 67.85 | Buy |
| 50-day EMA: | 67.02 | Buy |
| 200-day EMA: | 63.95 | Buy |
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.
Griffon Earnings Growth & GFF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.76 per share.
Xeris Biopharma Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Griffon Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||